ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

Amanda Kirane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.